Factors that mold the nuclear landscape of HIV-1 integration
- PMID: 33337475
- PMCID: PMC7826272
- DOI: 10.1093/nar/gkaa1207
Factors that mold the nuclear landscape of HIV-1 integration
Abstract
The integration of retroviral reverse transcripts into the chromatin of the cells that they infect is required for virus replication. Retroviral integration has far-reaching consequences, from perpetuating deadly human diseases to molding metazoan evolution. The lentivirus human immunodeficiency virus 1 (HIV-1), which is the causative agent of the AIDS pandemic, efficiently infects interphase cells due to the active nuclear import of its preintegration complex (PIC). To enable integration, the PIC must navigate the densely-packed nuclear environment where the genome is organized into different chromatin states of varying accessibility in accordance with cellular needs. The HIV-1 capsid protein interacts with specific host factors to facilitate PIC nuclear import, while additional interactions of viral integrase, the enzyme responsible for viral DNA integration, with cellular nuclear proteins and nucleobases guide integration to specific chromosomal sites. HIV-1 integration favors transcriptionally active chromatin such as speckle-associated domains and disfavors heterochromatin including lamina-associated domains. In this review, we describe virus-host interactions that facilitate HIV-1 PIC nuclear import and integration site targeting, highlighting commonalities among factors that participate in both of these steps. We moreover discuss how the nuclear landscape influences HIV-1 integration site selection as well as the establishment of active versus latent virus infection.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
Figures
Similar articles
-
HIV Capsid and Integration Targeting.Viruses. 2021 Jan 18;13(1):125. doi: 10.3390/v13010125. Viruses. 2021. PMID: 33477441 Free PMC article. Review.
-
Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsid.Elife. 2014 Dec 17;3:e04114. doi: 10.7554/eLife.04114. Elife. 2014. PMID: 25517934 Free PMC article.
-
CPSF6-Dependent Targeting of Speckle-Associated Domains Distinguishes Primate from Nonprimate Lentiviral Integration.mBio. 2020 Sep 29;11(5):e02254-20. doi: 10.1128/mBio.02254-20. mBio. 2020. PMID: 32994325 Free PMC article.
-
Remodeling of the Core Leads HIV-1 Preintegration Complex into the Nucleus of Human Lymphocytes.J Virol. 2020 May 18;94(11):e00135-20. doi: 10.1128/JVI.00135-20. Print 2020 May 18. J Virol. 2020. PMID: 32238582 Free PMC article.
-
Cellular and molecular mechanisms of HIV-1 integration targeting.Cell Mol Life Sci. 2018 Jul;75(14):2491-2507. doi: 10.1007/s00018-018-2772-5. Epub 2018 Feb 7. Cell Mol Life Sci. 2018. PMID: 29417178 Free PMC article. Review.
Cited by
-
Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus.J Virol. 2023 Nov 30;97(11):e0073223. doi: 10.1128/jvi.00732-23. Epub 2023 Oct 16. J Virol. 2023. PMID: 37843371 Free PMC article. Review.
-
Capsid-host interactions for HIV-1 ingress.Microbiol Mol Biol Rev. 2023 Dec 20;87(4):e0004822. doi: 10.1128/mmbr.00048-22. Epub 2023 Sep 26. Microbiol Mol Biol Rev. 2023. PMID: 37750702 Free PMC article. Review.
-
Tough Way In, Tough Way Out: The Complex Interplay of Host and Viral Factors in Nucleocytoplasmic Trafficking during HIV-1 Infection.Viruses. 2022 Nov 12;14(11):2503. doi: 10.3390/v14112503. Viruses. 2022. PMID: 36423112 Free PMC article. Review.
-
Spatial and Genomic Correlates of HIV-1 Integration Site Targeting.Cells. 2022 Feb 14;11(4):655. doi: 10.3390/cells11040655. Cells. 2022. PMID: 35203306 Free PMC article.
-
Retroviral integrase: Structure, mechanism, and inhibition.Enzymes. 2021;50:249-300. doi: 10.1016/bs.enz.2021.06.007. Epub 2021 Aug 23. Enzymes. 2021. PMID: 34861940 Free PMC article.
References
-
- Ganser B.K., Li S., Klishko V.Y., Finch J.T., Sundquist W.I.. Assembly and analysis of conical models for the HIV-1 core. Science. 1999; 283:80–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
